SeeQC, Inc. S-1/Aamended IPO prospectus

Executive Summary

SEEQC develops control, readout and quantum–classical interface chips for quantum-system manufacturers, rather than qubits or end-user computing services. Current revenue comes mainly from development, engineering and fabrication work: FY2025 revenue increased 420% to $4.16M, but H1 2026 growth slowed to 23.7%, while net loss widened to $(9.61)M. Its investment case depends on converting customer validation projects into standardized chip deployments whose commercial benefits remain unproven. This IPO is unpriced, with offering size, valuation and buyer ownership still blank; it is also a financing necessity following the loss of $64.9M of merger-contingent funding. Investors should distinguish promising infrastructure technology from a commercially established business and defer a valuation judgment until final terms establish dilution and funding runway.

The Offering

• Size and valuation: The preliminary offering leaves price, price range, shares sold and post-offering shares outstanding blank; gross proceeds, implied market capitalization, buyer ownership, revenue multiple and fully diluted valuation therefore cannot be computed. The underwriting describes a company share sale, whose economics remain unresolved.
• Distribution: Nasdaq application under SEQC, with listing approval required for closing. Cantor Fitzgerald and BTIG lead the underwriting, alongside Needham & Company and Craig-Hallum; the discount is up to 7.0%, with a 30-day additional-share option.
• Proceeds and settlement: Funds primarily support product development, capital expenditures and general operations. Offering expenses include an expected $2.0M payment to Allegro; the IPO is also expected to trigger $6.0M of stock issuance after lock-ups expire, valued using a contractual $1.3B pre-money valuation—not an IPO valuation. SEEQC may substitute $0.5M of additional stock for cash reimbursement.
• Capitalization bridge: Before the IPO, 6/30/2026 cash was $18.1M and equity $23.1M. IPO-related changes include converting 12.1M preferred shares into common, a stock split, accelerated restricted-stock vesting, Allegro and advisor issuances, insider-loan forgiveness and expenses. “After IPO” would additionally include net offering proceeds; those balances remain blank.
• Dilution: The filing warns that offering price will exceed net tangible assets per share, but leaves the per-share backing and gap blank. Outstanding options cover 3.26M shares at a $1.46 weighted-average exercise price; 0.521M restricted stock units and new plan reserves create additional dilution. These pre-split counts cannot establish final fully diluted ownership.
• Lock-ups: Executive officers, directors and substantially all stockholders generally face 180-day restrictions from the final prospectus date, subject to exceptions and underwriter waivers. Allegro issuance and employee-plan registrations can add sale supply afterward; the final pricing, delivery and expiry dates are not yet established.

Key Financial Highlights

$M except percentages; annual figures audited, interim figures unaudited. Balance sheets are before the IPO.

• Growth quality: $2.4M of FY2025’s revenue increase came from work under contracts signed in 2024; H1 growth principally reflected milestone timing on existing programs, not a changed project portfolio.
• Cost trajectory: H1 selling, general and administrative expense reached $6.18M, including $1.4M of additional IPO/financing professional fees. Grant offsets fell, amplifying losses despite improved gross margin.
• Cash versus earnings: Stock-based compensation and depreciation partly offset losses in OCF; capital expenditure adds to cash needs. H1 operating-plus-capital burn was half the ending cash balance, before settlement and other offering costs.
• Equity and funding: Preferred financing supported positive equity despite a $65.3M accumulated deficit. Preferred holders had $81.1M of liquidation priority before conversion; this is not debt. Annual tangible equity equaled reported equity.
• Accounting effects: FY2024 included a $1.49M convertible-note valuation loss, reducing comparability. Grants are expense offsets, not customer revenue; IPO-triggered vesting and loan forgiveness will add compensation expense.

Business Model and Growth Drivers

SEEQC combines superconducting digital logic with cryogenic electronics to move control closer to qubits, targeting fewer cables, lower heat and faster error-correction feedback. Its in-house foundry supports rapid design iterations, prototyping and limited production.

• Revenue mix: ≈95% of FY2025 revenue came from quantum-related activities, primarily engineering and integration; 5% came from fully commercialized products. Development revenue is generally recognized as work progresses, while fabrication revenue depends on delivery and acceptance.
• Customer concentration: U.S. government agencies supplied 52% of FY2025 revenue and Customer A another 26%. Government contracts generally permit termination for convenience, making program continuity more consequential than headline market forecasts.
• Management strategy: Convert validation projects into standardized deployments, broaden control/readout offerings and expand partnerships. Integration typically takes ≈12–24 months or longer; IBM, IQM, Rigetti and NVIDIA relationships provide ecosystem access, not proof of scaled adoption. A second manufacturing line with ITRI aims to improve capacity and resilience.

Governance and Control

• Voting and ownership: Common shares carry one vote each. Before offering-related changes, seven major holders collectively owned ≈57.3% on a preferred-converted basis; executives and directors reported 16.6% beneficial ownership, including exercisable awards. Final post-IPO percentages remain blank.
• Board protection: A staggered three-class board and 66⅔% removal/amendment thresholds constrain stockholder influence and takeover opportunities. Four directors are expected to qualify as independent.
• Insider benefits: Closing forgives $0.563M of John Levy’s loans and $0.141M of Oleg Mukhanov’s, plus company-funded tax gross-ups. Executive salary increases and liquidity-linked vesting also raise post-IPO costs.
• Equity incentives: New equity and employee purchase plans permit annual reserve increases of up to 5% and 1% of outstanding shares, respectively, through 2036; financing and liquidity milestones feature in executive awards.

Risk Assessment

• Reporting controls: Unremediated weaknesses in accounting staffing, segregation of duties and technology controls create reporting-error risk; emerging-growth-company exemptions defer auditor control attestation.
• Going concern and financing: Management identifies substantial doubt over continued operations, while lost merger funding, accelerating burn and settlement obligations make additional capital essential.
• Commercial concentration: A few customers and government programs dominate revenue, so cancellation, milestone delays or nonrenewal can materially disrupt funding and development.
• Technical adoption: Integrated architecture benefits remain unproven commercially, and customer in-house solutions or competing qubit modalities could reduce demand.
• Manufacturing execution: Specialized, sometimes single-source inputs and an expired foundry sublease expose production to supply disruption, facility uncertainty and scale-up failures.
• Key personnel: Dependence on specialized leadership and scarce technical employees means departures or recruitment failures could delay development and commercialization.
• Dilution and shareholder influence: Future financing, awards and settlement shares can reduce ownership, while protective governance provisions limit investors’ ability to challenge allocation decisions.

Investor Actionables

• Final terms: Calculate valuation, fully diluted ownership and cash runway after settlement, expenses and insider benefits; assess whether proceeds finance meaningful commercialization milestones.
• First public results: Watch standardized product revenue, customer diversification and OCF-plus-capital burn; durable adoption must replace milestone-driven growth.
• Controls and lock-up: Track remediation evidence and the final 180-day expiry, including Allegro issuance and employee share registrations that may increase market supply.